biology-technology-1/the-medzilla-report-3a-june-2009-employment-outlook-for-biotech-pharma-health-13134-3/;/a><br

Breaking Biology Technology:Oxford BioTherapeutics Appoints Michael Moore as Chairman 2 Oxford BioTherapeutics Appoints Michael Moore as Chairman 3 Oxford BioTherapeutics Appoints Michael Moore as Chairman 4 Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes 2 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 2 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 3 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 4 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 5 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 6 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 7 Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 8 The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 2 The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 3

[0] Oxford BioTherapeutics Appoints Michael Moore as Chairman [0] Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes [0] Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective [0] The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program

Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5 Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6 Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2 Skill Without a Question Luck Maybe a Bit Y E Yang Winning the War Between His Ears Absolutely 54608 1 Skill Without a Question Luck Maybe a Bit Y E Yang Winning the War Between His Ears Absolutely 54608 2 Skill Without a Question Luck Maybe a Bit Y E Yang Winning the War Between His Ears Absolutely 54608 3 Career Step Partners with SUNY Orange County Community College to Help Students Gain Careers in Growing Healthcare Industry 54604 1 Career Step Partners with SUNY Orange County Community College to Help Students Gain Careers in Growing Healthcare Industry 54604 2 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 1 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 2 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 3 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 4 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 5 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 6 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 7

[0] Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase [0] ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference [0] Giant Eagle(R) Pharmacy Receives Award for Operational Excellence